Northwestern University's Feinberg School of Medicine: New Anti-Obesity Medication Almost Twice as Effective as Most Currently Approved Weight-Loss Drugs
February 12, 2021
February 12, 2021
CHICAGO, Illinois, Feb. 12 (TNSJou) -- Northwestern University's Feinberg School of Medicine issued the following news release:
A new anti-obesity medication was shown to be almost twice as effective at helping individuals lose weight than some of the current weight-loss drugs on the market, according to a new landmark study conducted at Northwestern Medicine and other institutions and published in the New England Journal of Medicine.
The drug, semaglutide, taken o . . .
A new anti-obesity medication was shown to be almost twice as effective at helping individuals lose weight than some of the current weight-loss drugs on the market, according to a new landmark study conducted at Northwestern Medicine and other institutions and published in the New England Journal of Medicine.
The drug, semaglutide, taken o . . .